$64.8 Million is the total value of SOPHROSYNE CAPITAL LLC's 40 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 83.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $2,542,000 | -22.6% | 211,619 | +10.1% | 3.92% | +1.2% |
| CYNO | Buy | CYNOSURE INCcl a | $2,460,000 | +74.5% | 89,700 | +33.9% | 3.79% | +128.0% |
| RTK | Buy | RENTECH INC | $2,154,000 | -9.7% | 1,708,803 | +22.5% | 3.32% | +18.1% |
| AVAV | Buy | AEROVIRONMENT INC | $1,352,000 | +18.0% | 49,600 | +30.2% | 2.08% | +54.2% |
| IPHI | Buy | INPHI CORP | $1,260,000 | +181.2% | 68,300 | +118.2% | 1.94% | +267.3% |
| ENVI | Buy | ENVIVIO INC | $705,000 | -12.2% | 525,574 | +20.7% | 1.09% | +14.7% |
| REFR | New | RESEARCH FRONTIERS INC | $418,000 | – | 81,629 | +100.0% | 0.64% | – |
| CEMI | New | CHEMBIO DIAGNOSTICS INC | $407,000 | – | 103,400 | +100.0% | 0.63% | – |
| RNF | New | RENTECH NITROGEN PARTNERS L | $133,000 | – | 12,700 | +100.0% | 0.20% | – |
| GENC | New | GENCOR INDS INC | $114,000 | – | 12,150 | +100.0% | 0.18% | – |
| RVLT | New | REVOLUTION LIGHTING TECHNOLO | $102,000 | – | 75,279 | +100.0% | 0.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-01-26
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PURECYCLE CORP | 10 | Q3 2015 | 25.2% |
| MEETME INC | 9 | Q2 2015 | 8.3% |
| CADIZ INC | 9 | Q3 2015 | 6.6% |
| ENVIVIO INC | 9 | Q2 2015 | 3.3% |
| LIMONEIRA CO | 9 | Q3 2015 | 0.6% |
| ZELTIQ AESTHETICS INC | 8 | Q1 2015 | 10.3% |
| MICROSTRATEGY INC | 8 | Q1 2015 | 8.5% |
| BIODELIVERY SCIENCES INTL IN | 8 | Q1 2015 | 5.3% |
| PROCERA NETWORKS INC | 8 | Q1 2015 | 3.7% |
| AXOGEN INC | 8 | Q2 2015 | 5.6% |
View SOPHROSYNE CAPITAL LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ASPEN GROUP, INC. | February 12, 2016 | 1,690,490 | 1.3% |
| MeetMe, Inc. | April 07, 2014 | 1,855,835 | 4.8% |
| Venaxis, Inc.Sold out | January 29, 2014 | 0 | 0.0% |
| VENTRUS BIOSCIENCES INCSold out | January 29, 2014 | 0 | 0.0% |
| S&W Seed Co | October 01, 2013 | 554,213 | 4.8% |
| CardioNet, Inc. | September 23, 2013 | 1,038,518 | 4.1% |
| SMITH MICRO SOFTWARE INC | August 22, 2013 | 1,827,998 | 4.9% |
| Coastal Contacts Inc | June 14, 2013 | 1,100,263 | 3.4% |
| BIODELIVERY SCIENCES INTERNATIONAL INC | April 05, 2013 | 1,595,441 | 4.2% |
| Stereotaxis, Inc.Sold out | April 05, 2013 | 0 | 0.0% |
View SOPHROSYNE CAPITAL LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2016-02-12 |
| 13F-HR | 2015-11-13 |
| 13F-HR | 2015-08-14 |
| 13F-HR | 2015-04-20 |
| 13F-HR | 2015-01-26 |
| SC 13G/A | 2015-01-26 |
| 13F-HR | 2014-11-14 |
| SC 13G/A | 2014-09-10 |
| 13F-HR | 2014-08-14 |
| 13F-HR | 2014-05-14 |
View SOPHROSYNE CAPITAL LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.